Mindfulness therapy for patients with coronary heart disease: A systematic review and meta-analysis.
Weina Li, Xiaoqin Liao, Dandan Geng, Jiechao Yang, Hu Chen, Shuqin Hu, Mengqiao Dai
International Journal of Nursing Practice December 1, 2024 DOI: 10.1111/ijn.13276 (opens in new tab) via PubMed
Summary
AI-generated from the abstractA meta-analysis of eight studies with 802 participants found that mindfulness-based interventions reduced anxiety, depression, perceived stress, and systolic blood pressure in patients with coronary heart disease compared to control groups. There was no significant effect on diastolic blood pressure, quality of life, or body mass index. One study reported improved sleep quality in patients with acute myocardial infarction after percutaneous coronary intervention, but no significant effect on body mass index. The findings suggest mindfulness-based interventions benefit certain psychological and physiological outcomes in this population.
Study at a glance
| Characteristics | Systematic review and meta-analysis Peer reviewed |
|---|---|
| Sample size | 802 |
| Population | Patients with coronary heart disease |
| Intervention | Mindfulness-based interventions |
| Topics | Meditation |
| Keywords | Coronary heart disease Meta‐analysis Nursing Systematic review |
| Key finding | Mindfulness-based interventions significantly reduced anxiety, depression, perceived stress, and systolic blood pressure in patients with coronary heart disease, but did not significantly affect diastolic blood pressure, quality of life, or body mass index. |
Abstract
Coronary heart disease (CHD) is a prevalent cardiovascular disease with high mortality rates worldwide. Patients with CHD often experience adverse psychological stress related to the disease's diagnosis, treatment and recovery phases. This stress can hurt sleep quality and overall quality of life. Mindfulness-based interventions (MBIs) have been studied as a psychotherapeutic approach to alleviating the psychological stress associated with CHD. This study aimed to determine the effectives of MBIs for health outcomes in patients with CHD. A total of eight English-language databases were searched, and eight relevant studies were included in the analysis. The included studies were assessed for literature quality, and data were extracted and analysed using Review Manager 5.3. A total of eight studies involving 802 participants were included in the analysis. Compared to control groups, MBIs significantly reduced anxiety, depression, perceived stress, and systolic blood pressure. However, there was no significant effect on diastolic blood pressure, quality of life or body mass index. One study reported that MBIs significantly improved sleep quality in patients with acute myocardial infarction after percutaneous coronary intervention but had no significant effect on body mass index. MBIs had significant effects on anxiety and depression in patients with CHD, reduced perceived stress and were associated with reductions in systolic blood pressure and improvements in sleep quality. However, they did not significantly affect diastolic blood pressure, quality of life or body mass index.